Last Updated on March 10, 2022 by GlobeNewsWire
SANTA MONICA, Calif., March 10, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that its Chief Executive Officer, Dr. Roger Crystal, will participate in a fireside chat at the 32nd Annual Oppenheimer Healthcare Conference taking place virtually March 15 – March 17. Management will also host investor 1×1 meetings.
32nd Oppenheimer Annual Oppenheimer Healthcare Conference
March 15 – 17, 2022
Fireside chat on March 16 at 2:40 pm ET; hosting 1-on-1 meetings
A webcast of the presentation will be accessible on the Opiant website.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN(R) Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).
For Media and Investor Inquiries:
Ben Atkins, Opiant